Skip to main content
. Author manuscript; available in PMC: 2024 Aug 8.
Published in final edited form as: J Allergy Clin Immunol. 2024 Jun 13;154(2):435–446. doi: 10.1016/j.jaci.2024.03.029

Figure 1. Diagram of the enrollment of patients on biologics (PoB) and subjects not on biologics (NB) from the immunologically healthy control (IHC) cohort in our prospective, observational study.

Figure 1.

COVID-19, Coronavirus disease 2019; IS, immunosuppression; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.